Piedmont Investment Advisors’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,927
Closed -$389K 330
2020
Q1
$389K Buy
1,927
+55
+3% +$10.6K 0.02% 503
2019
Q4
$350K Sell
1,872
-300
-14% -$51.6K 0.01% 679
2019
Q3
$347K Buy
2,172
+122
+6% +$24.3K 0.01% 688
2019
Q2
$516K Buy
2,050
+489
+31% +$113K 0.02% 538
2019
Q1
$374K Sell
1,561
-7
-0.4% -$1.68K 0.02% 687
2018
Q4
$360K Buy
1,568
+439
+39% +$108K 0.02% 614
2018
Q3
$319K Buy
+1,129
New +$331K 0.01% 757
2018
Q1
Sell
-3,104
Closed -$670K 784
2017
Q4
$670K Sell
3,104
-160
-5% -$32.4K 0.01% 349
2017
Q3
$607K Buy
3,264
+10
+0.3% +$1.74K 0.01% 372
2017
Q2
$561K Buy
+3,254
New +$522K 0.01% 389

Other funds holding ICUI

Piedmont Investment Advisors's ICUI Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of ICU Medical (ICUI) in Q2 2020, closing a stake of 1,927 shares — an estimated $389K sold.

Piedmont Investment Advisors first reported a position in ICUI in Q2 2017 and held it in 10 quarters. The position peaked at $670K in Q4 2017. 294 funds tracked by Wall St. Rank hold ICUI as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining ICU Medical position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 1,927 ICU Medical shares in Q2 2020, an estimated $389K.
  • Piedmont Investment Advisors first reported a position in ICU Medical in Q2 2017 and held it in 10 quarters.
  • Piedmont Investment Advisors's ICU Medical position peaked at $670K in Q4 2017.
  • 294 funds tracked by Wall St. Rank held ICU Medical as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.